SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3zdj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D8C_A_SORA4000_0 (MALATE SYNTHASE G)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	3 / 3	GLN A 28 HIS A 289 PRO A 27	None	0.78A	1d8cA-3zdjA: undetectable	1d8cA-3zdjA: 16.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236 ARG A 244	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) SO4 A1291 ( 3.6A)	0.31A	1ghmA-3zdjA: 35.5	1ghmA-3zdjA: 31.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 LYS A 234 GLY A 236 ALA A 237	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A)	0.39A	1i2wA-3zdjA: 38.1	1i2wA-3zdjA: 38.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I2W_A_CFXA1300_2 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	4 / 5	TYR A 105 LEU A 169 THR A 235 ARG A 244	None None SO4 A1291 (-3.6A) SO4 A1291 ( 3.6A)	0.38A	1i2wA-3zdjA: 38.1	1i2wA-3zdjA: 38.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.39A	1i2wB-3zdjA: 38.2	1i2wB-3zdjA: 38.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIA_C_SAMC2293_0 (GLYCINE N-METHYLTRANSFERASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 12	ILE A 282 VAL A 44 ALA A 185 GLY A 245 LEU A 75	None	1.03A	1kiaC-3zdjA: undetectable	1kiaC-3zdjA: 23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBH_B_SAMB1293_0 (GLYCINE N-METHYLTRANSFERASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 12	ILE A 282 VAL A 44 ALA A 185 GLY A 245 LEU A 75	None	1.00A	1nbhB-3zdjA: undetectable	1nbhB-3zdjA: 23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OQ5_A_CELA701_2 (CARBONIC ANHYDRASE II)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	4 / 4	HIS A 112 VAL A 108 THR A 118 LEU A 138	None	1.49A	1oq5A-3zdjA: undetectable	1oq5A-3zdjA: 22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UDT_A_VIAA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 12	ALA A 126 ILE A 127 VAL A 80 ALA A 79 LEU A 199	None	1.32A	1udtA-3zdjA: undetectable	1udtA-3zdjA: 22.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	9 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 ASN A 170 LYS A 234 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.47A	1ymxA-3zdjA: 38.9	1ymxA-3zdjA: 44.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	9 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 ASN A 170 LYS A 234 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.45A	1ymxB-3zdjA: 39.1	1ymxB-3zdjA: 44.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_D_ASDD1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.05A	2vcvD-3zdjA: undetectable	2vcvD-3zdjA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_E_ASDE1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.02A	2vcvE-3zdjA: undetectable	2vcvE-3zdjA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_H_ASDH1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.01A	2vcvH-3zdjA: undetectable	2vcvH-3zdjA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_I_ASDI1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.08A	2vcvI-3zdjA: undetectable	2vcvI-3zdjA: 22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YGO_A_PCFA1213_1 (WNT INHIBITORY FACTOR 1)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	4 / 6	LEU A 220 ILE A 279 MET A 272 VAL A 103	None None SO4 A1292 (-4.1A) None	1.03A	2ygoA-3zdjA: undetectable	2ygoA-3zdjA: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZGW_A_ADNA1301_1 (BIOTIN--[ACETYL-COA- CARBOXYLASE] LIGASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	4 / 7	ARG A 65 GLU A 64 ALA A 185 ALA A 184	None	0.96A	2zgwA-3zdjA: undetectable	2zgwA-3zdjA: 21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EL0_A_1UNA201_2 (PROTEASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	6 / 9	LEU A 49 VAL A 249 ILE A 208 ILE A 198 ALA A 187 ILE A 260	None	1.46A	3el0B-3zdjA: undetectable	3el0B-3zdjA: 18.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	LYS A 73 TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236 GLY A 238	None None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.53A	3hlwA-3zdjA: 38.8	3hlwA-3zdjA: 43.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.49A	3hlwB-3zdjA: 38.9	3hlwB-3zdjA: 43.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	None None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.37A	3huoA-3zdjA: 38.9	3huoA-3zdjA: 43.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	6 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 GLY A 236 GLY A 238	None None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.37A	3huoB-3zdjA: 39.2	3huoB-3zdjA: 43.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	6 / 12	SER A 70 LYS A 73 ASN A 132 THR A 235 GLY A 236 ARG A 244	SO4 A1291 (-3.4A) None None SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 ( 3.6A)	1.04A	3mzeA-3zdjA: 20.9	3mzeA-3zdjA: 21.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.48A	3ny4A-3zdjA: 36.7	3ny4A-3zdjA: 41.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236 GLY A 238	None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.37A	3q07A-3zdjA: 38.8	3q07A-3zdjA: 43.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236 GLY A 238	None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.40A	3q07B-3zdjA: 39.0	3q07B-3zdjA: 43.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	9 / 12	SER A 70 TYR A 105 SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.39A	3sh8A-3zdjA: 36.6	3sh8A-3zdjA: 39.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.32A	3sh8B-3zdjA: 36.5	3sh8B-3zdjA: 39.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A)	0.38A	4euzA-3zdjA: 38.0	4euzA-3zdjA: 40.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 10	TYR A 105 ASN A 132 VAL A 216 LYS A 234 THR A 235 GLY A 236 ALA A 237 ARG A 244	None None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.49A	4fh2A-3zdjA: 43.4	4fh2A-3zdjA: 82.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 10	TYR A 105 SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236 ALA A 237 ARG A 244	None SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.47A	4fh2A-3zdjA: 43.4	4fh2A-3zdjA: 82.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1W_A_STRA402_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	4 / 7	VAL A 80 ILE A 142 LEU A 169 LEU A 162	None	0.88A	4l1wA-3zdjA: undetectable	4l1wA-3zdjA: 23.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	10 / 12	SER A 70 TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.35A	4n9kA-3zdjA: 38.1	4n9kA-3zdjA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	9 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.36A	4n9kB-3zdjA: 38.1	4n9kB-3zdjA: 38.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O2B_D_LOCD503_2 (TUBULIN BETA-2B CHAIN)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 12	CYH A 77 LEU A 81 LEU A 138 ILE A 127 ALA A 126	None	0.84A	4o2bD-3zdjA: undetectable	4o2bD-3zdjA: 20.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.68A	4pm5A-3zdjA: 38.6	4pm5A-3zdjA: 43.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	9 / 12	LYS A 73 TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236 ALA A 237 GLY A 238	None None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) None	0.69A	4pm7A-3zdjA: 38.6	4pm7A-3zdjA: 44.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	9 / 12	TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 ALA A 237 GLY A 238	None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) None	0.64A	4pm9A-3zdjA: 38.7	4pm9A-3zdjA: 43.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RTB_A_SAMA501_1 (HYDG PROTEIN)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	3 / 3	GLU A 48 ARG A 259 GLN A 28	None	0.95A	4rtbA-3zdjA: undetectable	4rtbA-3zdjA: 23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G48_B_1FLB1375_1 (DNA POLYMERASE III SUBUNIT BETA)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 9	LEU A 51 THR A 195 PRO A 257 ILE A 208 LEU A 207	None	1.45A	5g48B-3zdjA: undetectable	5g48B-3zdjA: 19.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.39A	5ghyA-3zdjA: 38.0	5ghyA-3zdjA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 TYR A 105 ASN A 132 ASN A 170 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) None None None SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	1.27A	5ghyA-3zdjA: 38.0	5ghyA-3zdjA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	8 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.38A	5ghyB-3zdjA: 38.1	5ghyB-3zdjA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 TYR A 105 ASN A 132 ASN A 170 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) None None None SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	1.23A	5ghyB-3zdjA: 38.1	5ghyB-3zdjA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	10 / 11	SER A 70 TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 ALA A 237 ARG A 244	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 (-3.9A) SO4 A1291 ( 3.6A)	0.40A	5ghzA-3zdjA: 38.1	5ghzA-3zdjA: 38.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	9 / 10	SER A 70 TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236 ARG A 244	SO4 A1291 (-3.4A) None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) SO4 A1291 ( 3.6A)	0.40A	5ghzB-3zdjA: 38.0	5ghzB-3zdjA: 38.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND7_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 12	GLU A 197 LEU A 148 LEU A 152 ARG A 83 LEU A 199	None	1.11A	5nd7B-3zdjA: undetectable	5nd7B-3zdjA: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UXC_A_ZITA306_1 (PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	4 / 7	THR A 149 PHE A 72 ASP A 179 LEU A 169	None	1.26A	5uxcA-3zdjA: undetectable	5uxcA-3zdjA: 26.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIW_B_LOCB504_2 (TUBULIN BETA CHAIN)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	5 / 12	CYH A 77 LEU A 81 LEU A 138 ILE A 127 ALA A 126	None	0.88A	5xiwB-3zdjA: undetectable	5xiwB-3zdjA: 14.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YVN_A_ACTA305_0 (GLUTATHIONE S-TRANSFERASE OMEGA-1)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	4 / 6	LEU A 169 LYS A 73 LEU A 76 LEU A 139	None	1.01A	5yvnA-3zdjA: undetectable	5yvnA-3zdjA: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.42A	6b5yB-3zdjA: 36.8	6b5yB-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.46A	6b5yD-3zdjA: 36.8	6b5yD-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.31A	6b68B-3zdjA: 37.0	6b68B-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	6 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.30A	6b68D-3zdjA: 36.8	6b68D-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.36A	6b69A-3zdjA: 36.8 6b69B-3zdjA: 37.0	6b69A-3zdjA: 15.09 6b69B-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.35A	6b69D-3zdjA: 36.9	6b69D-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.36A	6b6aB-3zdjA: 36.4	6b6aB-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.32A	6b6aD-3zdjA: 36.3	6b6aD-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.36A	6b6cA-3zdjA: 36.3	6b6cA-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.60A	6b6dA-3zdjA: 36.4	6b6dA-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.39A	6b6eA-3zdjA: 36.5	6b6eA-3zdjA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 GLY A 238	SO4 A1291 (-3.4A) SO4 A1291 (-3.1A) None SO4 A1291 (-3.3A) SO4 A1291 (-3.6A) SO4 A1291 (-3.3A) None	0.43A	6b6fA-3zdjA: 36.2	6b6fA-3zdjA: 15.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	3zdj	ENCA BETA-LACTAMASE (synthetic construct)	7 / 12	TYR A 105 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236 GLY A 238	None SO4 A1291 (-3.1A) None None SO4 A1291 (-3.3A) SO4 A1291 (-3.3A) None	0.46A	6c79A-3zdjA: 38.6	6c79A-3zdjA: 34.15

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1D8C_A_SORA4000_0","MALATE SYNTHASE G","3zdj","ENCA BETA-LACTAMASE","synthetic construct",3,"GLN A  28;HIS A 289;PRO A  27","None","0.78A","1d8cA-3zdjA:undetectable","1d8cA-3zdjA:16.09"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236;ARG A 244","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);SO4 A1291 ( 3.6A)","0.31A","1ghmA-3zdjA:35.5","1ghmA-3zdjA:31.14"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;LYS A 234;GLY A 236;ALA A 237","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A)","0.39A","1i2wA-3zdjA:38.1","1i2wA-3zdjA:38.95"],["1I2W_A_CFXA1300_2","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",4,"TYR A 105;LEU A 169;THR A 235;ARG A 244","None;None;SO4 A1291 (-3.6A);SO4 A1291 ( 3.6A)","0.38A","1i2wA-3zdjA:38.1","1i2wA-3zdjA:38.95"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.39A","1i2wB-3zdjA:38.2","1i2wB-3zdjA:38.95"],["1KIA_C_SAMC2293_0","GLYCINE N-METHYLTRANSFERASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"ILE A 282;VAL A  44;ALA A 185;GLY A 245;LEU A  75","None","1.03A","1kiaC-3zdjA:undetectable","1kiaC-3zdjA:23.66"],["1NBH_B_SAMB1293_0","GLYCINE N-METHYLTRANSFERASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"ILE A 282;VAL A  44;ALA A 185;GLY A 245;LEU A  75","None","1.00A","1nbhB-3zdjA:undetectable","1nbhB-3zdjA:23.66"],["1OQ5_A_CELA701_2","CARBONIC ANHYDRASE II","3zdj","ENCA BETA-LACTAMASE","synthetic construct",4,"HIS A 112;VAL A 108;THR A 118;LEU A 138","None","1.49A","1oq5A-3zdjA:undetectable","1oq5A-3zdjA:22.44"],["1UDT_A_VIAA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"ALA A 126;ILE A 127;VAL A  80;ALA A  79;LEU A 199","None","1.32A","1udtA-3zdjA:undetectable","1udtA-3zdjA:22.03"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","3zdj","ENCA BETA-LACTAMASE","synthetic construct",9,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;ASN A 170;LYS A 234;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.47A","1ymxA-3zdjA:38.9","1ymxA-3zdjA:44.15"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","3zdj","ENCA BETA-LACTAMASE","synthetic construct",9,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;ASN A 170;LYS A 234;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.45A","1ymxB-3zdjA:39.1","1ymxB-3zdjA:44.15"],["2VCV_D_ASDD1224_1","GLUTATHIONE S-TRANSFERASE A3","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.05A","2vcvD-3zdjA:undetectable","2vcvD-3zdjA:22.06"],["2VCV_E_ASDE1224_1","GLUTATHIONE S-TRANSFERASE A3","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.02A","2vcvE-3zdjA:undetectable","2vcvE-3zdjA:22.06"],["2VCV_H_ASDH1224_1","GLUTATHIONE S-TRANSFERASE A3","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.01A","2vcvH-3zdjA:undetectable","2vcvH-3zdjA:22.06"],["2VCV_I_ASDI1224_1","GLUTATHIONE S-TRANSFERASE A3","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.08A","2vcvI-3zdjA:undetectable","2vcvI-3zdjA:22.06"],["2YGO_A_PCFA1213_1","WNT INHIBITORY FACTOR 1","3zdj","ENCA BETA-LACTAMASE","synthetic construct",4,"LEU A 220;ILE A 279;MET A 272;VAL A 103","None;None;SO4 A1292 (-4.1A);None","1.03A","2ygoA-3zdjA:undetectable","2ygoA-3zdjA:19.63"],["2ZGW_A_ADNA1301_1","BIOTIN--[ACETYL-COA-CARBOXYLASE] LIGASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",4,"ARG A  65;GLU A  64;ALA A 185;ALA A 184","None","0.96A","2zgwA-3zdjA:undetectable","2zgwA-3zdjA:21.33"],["3EL0_A_1UNA201_2","PROTEASE;PROTEASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",6,"LEU A  49;VAL A 249;ILE A 208;ILE A 198;ALA A 187;ILE A 260","None","1.46A","3el0B-3zdjA:undetectable","3el0B-3zdjA:18.46"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"LYS A  73;TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236;GLY A 238","None;None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.53A","3hlwA-3zdjA:38.8","3hlwA-3zdjA:43.77"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.49A","3hlwB-3zdjA:38.9","3hlwB-3zdjA:43.77"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","None;None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.37A","3huoA-3zdjA:38.9","3huoA-3zdjA:43.77"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",6,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;GLY A 236;GLY A 238","None;None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.37A","3huoB-3zdjA:39.2","3huoB-3zdjA:43.77"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","3zdj","ENCA BETA-LACTAMASE","synthetic construct",6,"SER A  70;LYS A  73;ASN A 132;THR A 235;GLY A 236;ARG A 244","SO4 A1291 (-3.4A);None;None;SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 ( 3.6A)","1.04A","3mzeA-3zdjA:20.9","3mzeA-3zdjA:21.39"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.48A","3ny4A-3zdjA:36.7","3ny4A-3zdjA:41.33"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236;GLY A 238","None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.37A","3q07A-3zdjA:38.8","3q07A-3zdjA:43.77"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236;GLY A 238","None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.40A","3q07B-3zdjA:39.0","3q07B-3zdjA:43.77"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",9,"SER A  70;TYR A 105;SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.39A","3sh8A-3zdjA:36.6","3sh8A-3zdjA:39.03"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.32A","3sh8B-3zdjA:36.5","3sh8B-3zdjA:39.03"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A)","0.38A","4euzA-3zdjA:38.0","4euzA-3zdjA:40.91"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"TYR A 105;ASN A 132;VAL A 216;LYS A 234;THR A 235;GLY A 236;ALA A 237;ARG A 244","None;None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.49A","4fh2A-3zdjA:43.4","4fh2A-3zdjA:82.95"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"TYR A 105;SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236;ALA A 237;ARG A 244","None;SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.47A","4fh2A-3zdjA:43.4","4fh2A-3zdjA:82.95"],["4L1W_A_STRA402_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2","3zdj","ENCA BETA-LACTAMASE","synthetic construct",4,"VAL A  80;ILE A 142;LEU A 169;LEU A 162","None","0.88A","4l1wA-3zdjA:undetectable","4l1wA-3zdjA:23.15"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",10,"SER A  70;TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.35A","4n9kA-3zdjA:38.1","4n9kA-3zdjA:38.75"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",9,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.36A","4n9kB-3zdjA:38.1","4n9kB-3zdjA:38.75"],["4O2B_D_LOCD503_2","TUBULIN BETA-2B CHAIN","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"CYH A  77;LEU A  81;LEU A 138;ILE A 127;ALA A 126","None","0.84A","4o2bD-3zdjA:undetectable","4o2bD-3zdjA:20.22"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.68A","4pm5A-3zdjA:38.6","4pm5A-3zdjA:43.77"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3zdj","ENCA BETA-LACTAMASE","synthetic construct",9,"LYS A  73;TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236;ALA A 237;GLY A 238","None;None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);None","0.69A","4pm7A-3zdjA:38.6","4pm7A-3zdjA:44.15"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","3zdj","ENCA BETA-LACTAMASE","synthetic construct",9,"TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;ALA A 237;GLY A 238","None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);None","0.64A","4pm9A-3zdjA:38.7","4pm9A-3zdjA:43.23"],["4RTB_A_SAMA501_1","HYDG PROTEIN","3zdj","ENCA BETA-LACTAMASE","synthetic construct",3,"GLU A  48;ARG A 259;GLN A  28","None","0.95A","4rtbA-3zdjA:undetectable","4rtbA-3zdjA:23.26"],["5G48_B_1FLB1375_1","DNA POLYMERASE III SUBUNIT BETA","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"LEU A  51;THR A 195;PRO A 257;ILE A 208;LEU A 207","None","1.45A","5g48B-3zdjA:undetectable","5g48B-3zdjA:19.31"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.39A","5ghyA-3zdjA:38.0","5ghyA-3zdjA:38.75"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;TYR A 105;ASN A 132;ASN A 170;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);None;None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","1.27A","5ghyA-3zdjA:38.0","5ghyA-3zdjA:38.75"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",8,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.38A","5ghyB-3zdjA:38.1","5ghyB-3zdjA:38.75"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;TYR A 105;ASN A 132;ASN A 170;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);None;None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","1.23A","5ghyB-3zdjA:38.1","5ghyB-3zdjA:38.75"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",10,"SER A  70;TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;ALA A 237;ARG A 244","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 (-3.9A);SO4 A1291 ( 3.6A)","0.40A","5ghzA-3zdjA:38.1","5ghzA-3zdjA:38.75"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",9,"SER A  70;TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236;ARG A 244","SO4 A1291 (-3.4A);None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);SO4 A1291 ( 3.6A)","0.40A","5ghzB-3zdjA:38.0","5ghzB-3zdjA:38.75"],["5ND7_B_TA1B601_1","TUBULIN BETA-2B CHAIN","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"GLU A 197;LEU A 148;LEU A 152;ARG A  83;LEU A 199","None","1.11A","5nd7B-3zdjA:undetectable","5nd7B-3zdjA:20.22"],["5UXC_A_ZITA306_1","PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",4,"THR A 149;PHE A  72;ASP A 179;LEU A 169","None","1.26A","5uxcA-3zdjA:undetectable","5uxcA-3zdjA:26.05"],["5XIW_B_LOCB504_2","TUBULIN BETA CHAIN","3zdj","ENCA BETA-LACTAMASE","synthetic construct",5,"CYH A  77;LEU A  81;LEU A 138;ILE A 127;ALA A 126","None","0.88A","5xiwB-3zdjA:undetectable","5xiwB-3zdjA:14.54"],["5YVN_A_ACTA305_0","GLUTATHIONE S-TRANSFERASE OMEGA-1","3zdj","ENCA BETA-LACTAMASE","synthetic construct",4,"LEU A 169;LYS A  73;LEU A  76;LEU A 139","None","1.01A","5yvnA-3zdjA:undetectable","5yvnA-3zdjA:21.48"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.42A","6b5yB-3zdjA:36.8","6b5yB-3zdjA:15.09"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.46A","6b5yD-3zdjA:36.8","6b5yD-3zdjA:15.09"],["6B68_B_9F2B301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.31A","6b68B-3zdjA:37.0","6b68B-3zdjA:15.09"],["6B68_D_9F2D400_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",6,"SER A  70;SER A 130;ASN A 170;LYS A 234;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.30A","6b68D-3zdjA:36.8","6b68D-3zdjA:15.09"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.36A","6b69A-3zdjA:36.8;6b69B-3zdjA:37.0","6b69A-3zdjA:15.09;6b69B-3zdjA:15.09"],["6B69_D_9F2D301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.35A","6b69D-3zdjA:36.9","6b69D-3zdjA:15.09"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.36A","6b6aB-3zdjA:36.4","6b6aB-3zdjA:15.09"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.32A","6b6aD-3zdjA:36.3","6b6aD-3zdjA:15.09"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.36A","6b6cA-3zdjA:36.3","6b6cA-3zdjA:15.09"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.60A","6b6dA-3zdjA:36.4","6b6dA-3zdjA:15.09"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.39A","6b6eA-3zdjA:36.5","6b6eA-3zdjA:15.09"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;GLY A 238","SO4 A1291 (-3.4A);SO4 A1291 (-3.1A);None;SO4 A1291 (-3.3A);SO4 A1291 (-3.6A);SO4 A1291 (-3.3A);None","0.43A","6b6fA-3zdjA:36.2","6b6fA-3zdjA:15.09"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","3zdj","ENCA BETA-LACTAMASE","synthetic construct",7,"TYR A 105;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236;GLY A 238","None;SO4 A1291 (-3.1A);None;None;SO4 A1291 (-3.3A);SO4 A1291 (-3.3A);None","0.46A","6c79A-3zdjA:38.6","6c79A-3zdjA:34.15"]]